News for Sanofi Stock (SNY)

Press release: Online availability of Sanofi's half-year financial report for 2023

GlobeNewsWire • 07/28/23

Sanofi lifts earnings outlook on Dupixent sales, new drug launches

Reuters • 07/28/23

Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment

GlobeNewsWire • 07/28/23

Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact

PRNewsWire • 07/25/23

7 Blue-Chip Stocks That Are Screaming Buys Right Now: July 2023

InvestorPlace • 07/23/23

Sanofi expects infant RSV shot to roll out before respiratory virus season this fall

CNBC • 07/21/23

Sanofi: Powering Up And Offering Investors A Lot Of Potentials

Seeking Alpha • 07/20/23

Sanofi (SNY), AstraZeneca's RSV Antibody Gets FDA Nod in Infants

Zacks Investment Research • 07/18/23

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

Market Watch • 07/18/23

FDA Approves Antibody For RSV After Challenging 2022 Season

Forbes • 07/17/23

FDA approves Sanofi and AstraZeneca infant RSV vaccine

Market Watch • 07/17/23

FDA Approves First RSV Drug to Protect All Infants

WSJ • 07/17/23

FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV

CNBC • 07/17/23

US FDA approves Sanofi-AstraZeneca's preventive RSV therapy for babies

Reuters • 07/17/23

Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease

GlobeNewsWire • 07/17/23

Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases

Business Wire • 07/17/23

This is Why Sanofi (SNY) is a Great Dividend Stock

Zacks Investment Research • 07/11/23

International Wide-Moat Stocks On Sale - The July 2023 Heat Map

Seeking Alpha • 07/07/23

SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate

PRNewsWire • 06/29/23

Sanofi: EPS Momentum Driven By Dupixent, Vaccines Day On Tap

Seeking Alpha • 06/29/23

Sanofi reaffirms target to deliver over $10.9 bln in annual vaccine sales by 2030

Reuters • 06/29/23

Sanofi says it's back to the drawing board on mRNA flu vaccines

Reuters • 06/29/23

Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease

GlobeNewsWire • 06/29/23

Sanofi (SNY) Atopic Dermatitis Drug Meets Goals in Phase II Study

Zacks Investment Research • 06/28/23

Press Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody

GlobeNewsWire • 06/27/23